Search Results

You are looking at 1 - 10 of 173 items for :

  • valve disease x
  • Refine by Access: All content x
Clear All
Open access

Isaac Adembesa, Adriaan Myburgh, and Justiaan Swanevelder

,000 deaths and 33.4 million cases globally ( 1 ). The majority of these cases occur in the poorest regions of the world. RHD commonly affects the mitral, aortic and occasionally tricuspid valves. Rheumatic pulmonary valve disease is very rare. During heart

Open access

Erwan Donal, Elena Galli, Amedeo Anselmi, Auriane Bidaut, and Guillaume Leurent

increase in surgical risk, and may contraindicate open-heart surgery ( 4 ). Therefore, it is now possible to treat aortic, pulmonary, tricuspid valve disease and peri-prosthetic leaks by percutaneous approaches. These approaches are based on the

Open access

David Messika-Zeitoun, Ian G Burwash, and Thierry Mesana

is on the horizon. In contrast to many other cardiac conditions, there is no treatment to prevent or slow the progression of valve disease and the only curative treatment is the performance of a valve intervention, surgically or through a

Open access

Shaun Robinson, Liam Ring, Daniel X Augustine, Sushma Rekhraj, David Oxborough, Allan Harkness, Patrizio Lancellotti, and Bushra Rana

intervention ( 18 ). The commonest causes of moderate or severe MR include degenerative disease (also referred to as mitral valve prolapse (MVP)) accounting for around 60%, rheumatic valve disease seen in 15% and secondary MR responsible for approximately 20

Open access

Catrin Williams, Anca Mateescu, Emma Rees, Kirstie Truman, Claire Elliott, Bohdana Bahlay, Ailsa Wallis, and Adrian Ionescu

Introduction Heart valve disease is ‘the next cardiac epidemic’ ( 1 ) and imposes an increasing drain on health care resources ( 2 ). There are little data about the prevalence of heart valve disease in the old; in major published surveys ( 3

Open access

L D Hunter, M Monaghan, G Lloyd, A J K Pecoraro, A F Doubell, and P G Herbst

disease in New Zealand: not all valve disease is rheumatic . Cardiology in the Young 2011 21 436 – 443 . ( ) 8 Ranganathan N Lam JH Wigle ED Silver MD. Morphology of the human mitral valve. II. The value

Open access

John B Chambers and Richard P Steeds

Valve disease is increasing in prevalence as our population ages ( 1 ) and is commonly regarded as the next cardiac epidemic ( 2 ). Patients are increasingly hard to assess as a result of comorbidities, while more is feasible in terms of

Open access

Annari van Rensburg, Philip Herbst, and Anton Doubell

rare disease involving obstruction of the left ventricular outflow (valvular/subvalvular stenosis or coarctation) and inflow (parachute mitral valve or supravalvular mitral membrane) ( 5 ), is an uncommon yet interesting one as it serves to illustrate

Open access

Madalina Garbi and Mark J Monaghan

valve disease, being essential for management planning ( 1 , 2 , 3 , 4 ). Quantitative analysis is an integral part of morphology assessment and provides objective evidence for the classification of findings within the normal or abnormal range and

Open access

Patrick Savage and Michael Connolly

Background Mitral valve repair is the gold standard treatment for degenerative mitral valve disease with superior perioperative and long-term morbidity and mortality outcomes vs mitral valve replacement. The 10 year survival freedom from redo